Horizon therapeutics plc announces pricing of public offering of ordinary shares

Horizon therapeutics plc (nasdaq: hznp) today announced the pricing of its underwritten public offering of 11,800,000 of its ordinary shares at a pric
MS Ratings Summary
MS Quant Ranking